BioVoice News eMag November-December 2023 | Page 22

C O V E R S T O R Y

Making breast cancer diagnostics accessible

NIRAMAI Health Analytix

AI-based early-stage breast cancer screening devices that are accurate , affordable and for women of all ages

Bengaluru based NIRAMAI Health Analytix is a deeptech healthcare startup offering a novel Artificial Intelligence-based , affordable , accessible , radiation-free , non-touch , accurate , breast cancer screening test for women of all age groups . The solution is accurate , affordable , privacy-aware , and can be used for women of all ages .

NIRAMAI solution has been awarded 10 granted US patents , 3 Indian patents , 2 Chinese and Singapore patents . The company is the first Indian startup to get a US FDA clearance for a software based medical device in women health . The SMILE-
Company : NIRAMAI Health Analytix Location : Bengaluru Year of Inception : 2016
Founder , CEO & CTO : Geetha Manjunath , Nidhi Mathur
Investors : Dream Incubator , BeeNext , pi Ventures , Ankur Capital , Axilor Ventures , 500 Startups , and Flipkart co-founder Binny Bansal
Latest Funding : Series A / Undisclosed , Grant ( prize money ), June 29 , 2021
100 System is a breast thermography device that helps healthcare personnel to review , measure and analyze thermally significant indications in the breast region . It can be used in the hospital , acute care settings , outpatient surgery , healthcare practitioner facilities or an environment where patient care is provided by qualified healthcare personnel . It is intended for use as adjunctive diagnostic imaging for thermally significant indications in the breast region .
Co-founded in July 2016 by Dr Geetha
22
BioVoiceNews | November / December 2023